{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:00Z","timestamp":1792601520809,"version":"4.5.0"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The most prevalent kind of acute leukemia in adults is acute myeloid leukemia (AML). While some individuals have had better effectiveness due to advancements in targeted medications, recurrence after remission and inadequate treatment specificity continue to be significant therapeutic problems. By controlling essential metabolic pathways and metabolites, metabolic reprogramming, a crucial strategy for cellular adaptability to energy needs, modifies cellular metabolic rhythms. In addition to being involved in immune cell proliferation, differentiation, and effector function, this pathway is also essential for leukemogenesis and survival signaling in AML. By altering the expression of immune molecules, the release of certain metabolites (such as lactate, ROS, glutamine, etc.) has a significant impact on the immune response to tumors. It is noteworthy that the metabolic interactions between immune cells and AML cells form a distinct pattern of energy competition in the tumor microenvironment. This study examined the new approach of targeting metabolic pathways to improve immunotherapy, systematically clarified the regulatory mechanism of metabolic reprogramming between AML cells and immune cells to counteract tumor immunity, and concentrated on the synergistic effect of current therapies and metabolic interventions. These findings offered a fresh perspective on how to fully realize the potential of metabolic therapy for AML.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1655005","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:47:04Z","timestamp":1765349224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic reprogramming and immune regulation in acute myeloid leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaogang","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reaila","family":"Jianati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengda","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyulong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","article-title":"Acute myeloid leukemia management and research in 2025","volume":"75","author":"Kantarjian","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: A review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12032-020-01394-6","article-title":"Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target","volume":"37","author":"Lapa","year":"2020","journal-title":"Med Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13578-023-01138-9","article-title":"Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling","volume":"13","author":"Jin","year":"2023","journal-title":"Cell Biosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018092","article-title":"Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets","volume":"141","author":"Mishra","year":"2023","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417422","article-title":"The role of tumor metabolic reprogramming in tumor immunity","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological Malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136857","article-title":"The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities","volume":"22","author":"Bruno","year":"2021","journal-title":"IJMS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824562","article-title":"Acute myeloid leukemia cells functionally compromise hematopoietic stem\/progenitor cells inhibiting normal hematopoiesis through the release of extracellular vesicles","volume":"12","author":"Trino","year":"2022","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cells8090967","article-title":"Targeting metabolic reprogramming in acute myeloid leukemia","volume":"8","author":"Castro","year":"2019","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.85","article-title":"Altered metabolite levels in cancer: implications for tumour biology and cancer therapy","volume":"16","author":"Sullivan","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2023.12","article-title":"Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia","volume":"6","author":"Sharma","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"B14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00927-3","article-title":"A century of the Warburg effect","volume":"5","author":"Thompson","year":"2023","journal-title":"Nat Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.004","article-title":"Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway","volume":"14","author":"Bao","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100786","article-title":"Metabolic regulation of the bone marrow microenvironment in leukemia","volume":"48","author":"Xu","year":"2021","journal-title":"Blood Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.10.001","article-title":"Extinguishing the embers: targeting AML metabolism","volume":"27","author":"Culp-Hill","year":"2021","journal-title":"Trends Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00031.2021","article-title":"Trained immunity: adaptation within innate immune mechanisms","volume":"103","author":"Dom\u00ednguez-Andr\u00e9s","year":"2023","journal-title":"Physiol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinh\u00e4user","year":"2023","journal-title":"Sci Adv"},{"key":"B24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","article-title":"The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways","volume":"21","author":"Bakhtiyari","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02469-3","article-title":"Glucose uptake capacity of leukaemia cells in vitro correlates with response to induction therapy in acute myeloid leukaemia","volume":"39","author":"Deng","year":"2024","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1186\/s12967-024-05779-3","article-title":"Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"B28","article-title":"Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8+ cytolytic T cells","volume":"11","author":"Chen","year":"2021","journal-title":"Am J Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001034","article-title":"Amino acid metabolism in hematologic Malignancies and the era of targeted therapy","volume":"134","author":"Tabe","year":"2019","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102700","article-title":"A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment","volume":"10","author":"Hofer","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030756","article-title":"Molecular systems architecture of interactome in the acute myeloid leukemia microenvironment","volume":"14","author":"Ayyadurai","year":"2022","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors","volume":"108","author":"Le Floch","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41467-022-29639-0","article-title":"Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0291","article-title":"Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia","volume":"84","author":"Monteith","year":"2024","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2018.08.005","article-title":"AXL mediates esophageal adenocarcinoma cell invasion through regulation of extracellular acidification and lysosome trafficking","volume":"20","author":"Maacha","year":"2018","journal-title":"Neoplasia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20294","article-title":"Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells","volume":"8","author":"Lopes-Coelho","year":"2017","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1\u03b1-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1042\/bj3500219","article-title":"The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells","author":"Dimmer","year":"2000","journal-title":"Biochem J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483400","article-title":"Lactate\u2019s impact on immune cells in sepsis: unraveling the complex interplay","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12935-024-03520-0","article-title":"Acid affairs in anti-tumour immunity","volume":"24","author":"Cappellesso","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111765","article-title":"Lactate acid promotes PD-1+ Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia","volume":"130","author":"Zhang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12935-024-03555-3","article-title":"Analysis of immune status and prognostic model incorporating lactic acid metabolism-associated genes","volume":"24","author":"Bao","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.13.566874","article-title":"Elevated lactate in the AML bone marrow microenvironment polarizes leukemia-associated macrophages via GPR81 signaling","volume":"6","author":"Soto","year":"2025","journal-title":"bioRxiv"},{"key":"B46","doi-asserted-by":"publisher","first-page":"eabb8969","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020313","article-title":"Functions of ROS in macrophages and antimicrobial immunity","volume":"10","author":"Herb","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0445","article-title":"Reactive oxygen species modulation in the current landscape of anticancer therapies","volume":"41","author":"Li","year":"2024","journal-title":"Antioxidants Redox Signaling"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e6806","DOI":"10.1002\/cam4.6806","article-title":"Oxidative stress is two-sided in the treatment of acute myeloid leukemia","volume":"13","author":"Fan","year":"2024","journal-title":"Cancer Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652687","article-title":"Metabolic reprogramming and reactive oxygen species in T cell immunity","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.150","article-title":"Oxidative stress and autophagy: the clash between damage and metabolic needs","volume":"22","author":"Filomeni","year":"2015","journal-title":"Cell Death Differ"},{"key":"B52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42255-022-00550-8","article-title":"Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils","volume":"4","author":"Britt","year":"2022","journal-title":"Nat Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-022-01002-x","article-title":"Metabolic communication in the tumour\u2013immune microenvironment","volume":"24","author":"Kao","year":"2022","journal-title":"Nat Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"189257","DOI":"10.1016\/j.bbcan.2024.189257","article-title":"Targeting glutamine metabolism crosstalk with tumor immune response","volume":"1880","author":"Dong","year":"2024","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41416-019-0626-z","article-title":"Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer","volume":"122","author":"Ansari","year":"2020","journal-title":"Br J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01104-0","article-title":"Targeting glutamine metabolism as an attractive therapeutic strategy for acute myeloid leukemia","volume":"24","author":"Xiao","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-024-01557-2","article-title":"PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Zhou","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","article-title":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1386517","article-title":"Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells","volume":"15","author":"Corradi","year":"2024","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111412","article-title":"Murine regulatory CD4+ T cells are increased in leukemic spleens and show high co-expression of co-regulatory molecules CD39, CD73, PD1, and TIGIT","volume":"25","author":"Kr\u00fcger","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40164-024-00534-2","article-title":"Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion","volume":"13","author":"Klaihmon","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-022-01635-4","article-title":"Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia","volume":"21","author":"Zhai","year":"2022","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050676","article-title":"mTORC1\/ERK1\/2 interplay regulates protein synthesis and survival in acute myeloid leukemia cell lines","volume":"12","author":"Germano","year":"2023","journal-title":"Biol (Basel)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111211","article-title":"Combination therapy of acute myeloid leukemia by dual PI3K\/mTOR inhibitor BEZ235 and TLR-7\/8 agonist R848 in murine model","volume":"125","author":"Taghiloo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B65","unstructured":"N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2 - PMC\n          \n          38822351"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2021","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00771-7","article-title":"Detoxified pneumolysin derivative \u0394A146Ply inhibits autophagy and induces apoptosis in acute myeloid leukemia cells by activating mTOR signaling","volume":"54","author":"Zhu","year":"2022","journal-title":"Exp Mol Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215659","article-title":"Adenosine Monophosphate Activated Protein Kinase (AMPK) enhances chemotherapy response in Acute Myeloid Leukemia (AML)","volume":"535","author":"Ghiraldeli","year":"2022","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700374","article-title":"Distinct bioenergetic features of human invariant natural killer T cells enable retained functions in nutrient-deprived states","volume":"12","author":"Khurana","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116352","article-title":"Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles","volume":"269","author":"Frazier","year":"2024","journal-title":"Eur J Medicinal Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009444","article-title":"AMPK activation induces immunogenic cell death in AML","volume":"7","author":"Mondesir","year":"2023","journal-title":"Blood Adv"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001076","article-title":"AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia","volume":"134","author":"Jiang","year":"2019","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283597","article-title":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells","volume":"109","author":"Hammon","year":"2024","journal-title":"Haematologica"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009854","article-title":"Olutasidenib: from bench to bedside","volume":"7","author":"Venugopal","year":"2023","journal-title":"Blood Adv"},{"key":"B75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/bjh.19519","article-title":"Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease","volume":"205","author":"Jen","year":"2024","journal-title":"Br J Haematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009411","article-title":"Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML","volume":"7","author":"De Botton","year":"2023","journal-title":"Blood Adv"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.651687","article-title":"Investigating the role of indoleamine 2, 3-dioxygenase in acute myeloid leukemia: A systematic review","volume":"12","author":"Wells","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s44313-024-00048-0","article-title":"Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting","volume":"59","author":"Hakak","year":"2024","journal-title":"Blood Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1182\/bloodadvances.2021004878","article-title":"An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia","volume":"6","author":"Ragaini","year":"2022","journal-title":"Blood Adv"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1392","article-title":"Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma","volume":"27","author":"Zhai","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01349-3","article-title":"SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming","volume":"26","author":"Xu","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016580","article-title":"PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371","volume":"141","author":"Chen","year":"2023","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10565-024-09965-3","article-title":"Targeting protein tyrosine phosphatase non-receptor type 6 (PTPN6) as a therapeutic strategy in acute myeloid leukemia","volume":"41","author":"Wang","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100503","article-title":"Synergistic targeting of DNA-PK and KIT signaling pathways in KIT mutant acute myeloid leukemia","volume":"22","author":"Murray","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211221","article-title":"Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","article-title":"Crosstalk between glucose metabolism, lactate production and immune response modulation","volume":"68","author":"Ye","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1182\/hematology.2019000045","article-title":"Inflammatory bone marrow microenvironment","volume":"2019","author":"Leimk\u00fchler","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2024.11.004","article-title":"Implications for metabolic disturbances in myelodysplastic syndromes","volume":"61","author":"McGraw","year":"2024","journal-title":"Semin Hematol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"\u0160krti\u0107","year":"2011","journal-title":"Cancer Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1244280","article-title":"Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia","volume":"13","author":"Feng","year":"2023","journal-title":"Front Oncol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/j.cell.2023.06.002","article-title":"Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity","volume":"186","author":"Ma","year":"2023","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","article-title":"Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine","volume":"14","author":"Buettner","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.02.002","article-title":"Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications","volume":"86","author":"Greene","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"eabm8182","DOI":"10.1126\/sciimmunol.abm8182","article-title":"OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment","volume":"7","author":"Hong","year":"2022","journal-title":"Sci Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.cmet.2021.11.010","article-title":"Coenzyme A fuels T cell anti-tumor immunity","volume":"33","author":"St. Paul","year":"2021","journal-title":"Cell Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e20221472","DOI":"10.1084\/jem.20221472","article-title":"Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages","volume":"220","author":"Gonzalez","year":"2023","journal-title":"J Exp Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.immuni.2023.01.011","article-title":"Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis","volume":"56","author":"Wculek","year":"2023","journal-title":"Immunity"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102575","article-title":"NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation","volume":"59","author":"Sen","year":"2022","journal-title":"Redox Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.021","article-title":"Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.70000","article-title":"Reprogramming of fatty acid metabolism in acute leukemia","volume":"240","author":"Sokei","year":"2025","journal-title":"J Cell Physiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41574-024-01043-2","article-title":"Brown adipose tissue fights the battle against leukaemia","volume":"20","author":"Fischer-Posovszky","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01011-2","article-title":"Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity","volume":"20","author":"Grajchen","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13215","article-title":"Lipid metabolism in dendritic cell biology","volume":"317","author":"You","year":"2023","journal-title":"Immunol Rev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179178","article-title":"Metabolic function and therapeutic potential of CD147 for hematological Malignancies: an overview","volume":"25","author":"Spinello","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.990034","article-title":"Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis","volume":"10","author":"Lu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.05.006","article-title":"GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy","volume":"32","author":"Shi","year":"2024","journal-title":"Mol Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101580","article-title":"Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00812-x","article-title":"Targeting human mitochondrial NAD(P)+-dependent Malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia","volume":"46","author":"Chen","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e12168","DOI":"10.1002\/jev2.12168","article-title":"Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia","volume":"10","author":"Peng","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645605","article-title":"P2X7 receptor in hematological Malignancies","volume":"9","author":"De Marchi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.19746\/j.cnki.issn.1009-2137.2023.05.006","article-title":"Effects of methionine restriction on proliferation, cell cycle, and apoptosis of human acute leukemia cells","volume":"31","author":"He","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nature22314","article-title":"Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia","volume":"545","author":"Hattori","year":"2017","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26903","article-title":"Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid Malignancies patients prior to allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Tang","year":"2023","journal-title":"Am J Hematol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/bloodadvances.2023010786","article-title":"The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia","volume":"8","author":"Cunningham","year":"2023","journal-title":"Blood Adv"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279889","article-title":"The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias","volume":"107","author":"Paolillo","year":"2022","journal-title":"Haematologica"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1302356","article-title":"Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia","volume":"13","author":"Ke","year":"2023","journal-title":"Front Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-023-00975-8","article-title":"Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations","volume":"14","author":"Tien","year":"2024","journal-title":"Blood Cancer J"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112059","article-title":"NK cell defects: implication in acute myeloid leukemia","volume":"14","author":"D\u2019Silva","year":"2023","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030787","article-title":"Nicotinaldehyde, a novel precursor of NAD biosynthesis, abrogates the anti-cancer activity of an NAD-lowering agent in leukemia","volume":"15","author":"Matsumoto","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12672-024-01245-0","article-title":"Glutamine and leukemia research: progress and clinical prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Discov Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-025-01270-4","article-title":"Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days","volume":"15","author":"Gangat","year":"2025","journal-title":"Blood Cancer J"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012302","article-title":"Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed\/refractory myelodysplastic syndrome","volume":"8","author":"DiNardo","year":"2024","journal-title":"Blood Adv"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16296","article-title":"Fatty acid metabolism in adaptive immunity","volume":"290","author":"Zhou","year":"2023","journal-title":"FEBS J"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01657-z","article-title":"Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1\/2 trial","volume":"18","author":"Cortes","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730970","article-title":"Chronic IL-15 stimulation and impaired mTOR signaling and metabolism in natural killer cells during acute myeloid leukemia","volume":"12","author":"Bou-Tayeh","year":"2021","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010460","article-title":"GPRC5C drives branched-chain amino acid metabolism in leukemogenesis","volume":"7","author":"Zhang","year":"2023","journal-title":"Blood Adv"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012529","article-title":"Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia","volume":"8","author":"Slezak","year":"2024","journal-title":"Blood Adv"},{"key":"B133","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: From bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12964-024-01774-9","article-title":"Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting \u03b2-catenin activity via the PP2A-GSK3\u03b2 axis","volume":"22","author":"Jiang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040852","article-title":"Cell intrinsic and systemic metabolism in tumor immunity and immunotherapy","volume":"12","author":"Coleman","year":"2020","journal-title":"Cancers"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2261631","article-title":"OXPHOS-targeting drugs in oncology: New perspectives","volume":"27","author":"Kalyanaraman","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202403409","article-title":"Advances in drug delivery systems for the treatment of acute myeloid leukemia","volume":"20","author":"Wu","year":"2024","journal-title":"Small"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03271-5","article-title":"Cytokine-mediated CAR T therapy resistance in AML","volume":"30","author":"Bhagwat","year":"2024","journal-title":"Nat Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00434-9","article-title":"Strategies to enhance CAR-T persistence","volume":"10","author":"Liu","year":"2022","journal-title":"biomark Res"},{"key":"B140","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajh.27584","article-title":"Treatment of relapsed\/refractory AML-novel treatment options including immunotherapy","volume":"100","author":"Moore","year":"2025","journal-title":"Am J Hematol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0202","article-title":"Recent advances in immune-based therapies for acute myeloid leukemia","volume":"5","author":"Restelli","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.ccell.2023.09.010","article-title":"Cooperative CAR targeting to selectively eliminate AML and minimize escape","volume":"41","author":"Haubner","year":"2023","journal-title":"Cancer Cell"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027364","article-title":"Novel CAR T cells to combat antigen escape in AML","volume":"145","author":"El Khawanky","year":"2025","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.05.006","article-title":"Acute leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a latin american population","volume":"29","author":"Arias-Espinosa","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757836","article-title":"Recent metabolic advances for preventing and treating acute and chronic graft versus host disease","volume":"12","author":"Mohamed","year":"2021","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112605","article-title":"Hematopoietic stem cell: regulation and nutritional intervention","volume":"15","author":"Sun","year":"2023","journal-title":"Nutrients"},{"key":"B147","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13287-024-04126-z","article-title":"Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation","volume":"16","author":"Aljagthmi","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.05.007","article-title":"A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy","volume":"13","author":"Sun","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1118-z","article-title":"Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation","volume":"60","author":"Ersv\u00e6r","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1453886","article-title":"Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy","volume":"15","author":"Ahn","year":"2024","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained immunity: reprogramming innate immunity in health and disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B152","doi-asserted-by":"crossref","unstructured":"Outcomes of patients with newly diagnosed AML and hyperleukocytosis\n          \n          \n            \n              Haddad\n              FG\n            \n            \n              Sasaki\n              K\n            \n            \n              Senapati\n              J\n            \n            \n              Xiao\n              L\n            \n            \n              Park\n              G\n            \n            \n              Abuasab\n              T\n            \n          \n          10.1200\/OP.24.00027\n          39013130\n          JCO Oncol Pract\n          20\n          2024","DOI":"10.1200\/OP.24.00027"},{"key":"B153","doi-asserted-by":"publisher","first-page":"993","DOI":"10.7150\/thno.104872","article-title":"Metformin-based nanomedicines for reprogramming tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061171","article-title":"Enhancing leukemia treatment: The role of combined therapies based on amino acid starvation","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.02.002","article-title":"Unlocking potential: the role of the electron transport chain in immunometabolism","volume":"45","author":"Zotta","year":"2024","journal-title":"Trends Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010355","article-title":"Sintilimab plus decitabine for higher-risk treatment-na\u00efve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trial","volume":"12","author":"Wang","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170065","article-title":"PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia","volume":"8","author":"Carlock","year":"2023","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:47:08Z","timestamp":1765349228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2025.1655005"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1655005","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1655005"}}